• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Risk factors for mortality in patients with alcoholic hepatitis and assessment of prognostic models: A population-based study.酒精性肝炎患者死亡的危险因素及预后模型评估:一项基于人群的研究。
Can J Gastroenterol Hepatol. 2015 Apr;29(3):131-8. doi: 10.1155/2015/814827.
2
Predicting short-term and long-term mortality of hospitalized Portuguese patients with alcoholic hepatitis.预测葡萄牙住院酒精性肝炎患者的短期和长期死亡率。
Eur J Gastroenterol Hepatol. 2017 Oct;29(10):1141-1148. doi: 10.1097/MEG.0000000000000926.
3
Evaluation of MELD score and Maddrey discriminant function for mortality prediction in patients with alcoholic hepatitis.评估终末期肝病模型(MELD)评分和马德雷判别函数对酒精性肝炎患者死亡率的预测价值。
Hepatogastroenterology. 2013 Jul-Aug;60(125):1089-94. doi: 10.5754/hge11969.
4
[Comparison of model for end-stage liver disease score with discriminant function and child-Turcotte-Pugh scores for predicting short-term mortality in Korean patients with alcoholic hepatitis].[终末期肝病模型评分与判别函数及Child-Turcotte-Pugh评分在预测韩国酒精性肝炎患者短期死亡率中的比较]
Korean J Gastroenterol. 2007 Feb;49(2):93-9.
5
Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort.酒精性肝炎短期死亡率的九种评分模型:在经活检证实的队列中的交叉验证
Aliment Pharmacol Ther. 2014 Apr;39(7):721-32. doi: 10.1111/apt.12654.
6
Model for end-stage liver disease score versus Maddrey discriminant function score in assessing short-term outcome in alcoholic hepatitis.在评估酒精性肝炎短期预后方面,终末期肝病评分与马德雷判别函数评分的比较模型
J Gastroenterol Hepatol. 2014 Mar;29(3):581-8. doi: 10.1111/jgh.12400.
7
Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis.联合应用肝脏疾病评分系统的数据可更好地预测酒精性肝炎患者的预后。
Gastroenterology. 2015 Aug;149(2):398-406.e8; quiz e16-7. doi: 10.1053/j.gastro.2015.04.044. Epub 2015 Apr 29.
8
The amount of alcohol consumption negatively impacts short-term mortality in Mexican patients with alcoholic hepatitis.酒精摄入量的多少对患有酒精性肝炎的墨西哥患者的短期死亡率有负面影响。
Am J Gastroenterol. 2011 Aug;106(8):1472-80. doi: 10.1038/ajg.2011.141. Epub 2011 May 10.
9
MELD accurately predicts mortality in patients with alcoholic hepatitis.终末期肝病模型(MELD)能准确预测酒精性肝炎患者的死亡率。
Hepatology. 2005 Feb;41(2):353-8. doi: 10.1002/hep.20503.
10
The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study.MELD 评分优于 Maddrey 判别函数评分预测酒精性肝炎短期死亡率:全球研究。
Am J Gastroenterol. 2022 Feb 1;117(2):301-310. doi: 10.14309/ajg.0000000000001596.

引用本文的文献

1
Sex differences in severity, outcomes, and healthcare utilization in alcohol-associated hepatitis.酒精性肝炎在严重程度、预后及医疗利用方面的性别差异。
World J Hepatol. 2025 Aug 27;17(8):108063. doi: 10.4254/wjh.v17.i8.108063.
2
Alcohol-induced KDM5B activation in hepatocytes drives pathogenic cell-cell communication, leading to loss of liver function.酒精诱导的肝细胞中KDM5B激活驱动致病性细胞间通讯,导致肝功能丧失。
Hepatol Commun. 2025 Aug 15;9(9). doi: 10.1097/HC9.0000000000000771. eCollection 2025 Sep 1.
3
Short-term costs of alcohol-associated hepatitis care in different clinical settings.不同临床环境下酒精性肝炎护理的短期成本。
Hepatol Commun. 2025 Jan 29;9(2). doi: 10.1097/HC9.0000000000000634. eCollection 2025 Feb 1.
4
Androgen Effects on Alcohol-induced Liver Fibrosis Are Controlled by a Notch-dependent Epigenetic Switch.雄激素对酒精性肝纤维化的影响受Notch依赖的表观遗传开关调控。
Cell Mol Gastroenterol Hepatol. 2025;19(1):101414. doi: 10.1016/j.jcmgh.2024.101414. Epub 2024 Sep 28.
5
Protective role of 17β-estradiol in alcohol-associated liver fibrosis is mediated by suppression of integrin signaling.17β-雌二醇通过抑制整合素信号通路在酒精相关性肝纤维化中发挥保护作用。
Hepatol Commun. 2024 May 3;8(5). doi: 10.1097/HC9.0000000000000428. eCollection 2024 May 1.
6
Alcohol-related hepatitis admissions decline in 2021 after a 2020 surge attributed to the COVID-19 pandemic.2020 年因 COVID-19 大流行导致与酒精相关的肝炎入院人数激增,此后,2021 年该人数有所下降。
Hepatol Int. 2023 Dec;17(6):1637-1644. doi: 10.1007/s12072-023-10569-y. Epub 2023 Jul 28.
7
Determining Prognosis of ALD and Alcohol-associated Hepatitis.确定酒精性肝病(ALD)和酒精性肝炎的预后
J Clin Exp Hepatol. 2023 May-Jun;13(3):479-488. doi: 10.1016/j.jceh.2022.10.010. Epub 2022 Nov 3.
8
Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis.全球酒精相关性肝病的患病率、发病率和结局:系统评价和荟萃分析。
BMC Public Health. 2023 May 11;23(1):859. doi: 10.1186/s12889-023-15749-x.
9
A Pathogenic Role of Non-Parenchymal Liver Cells in Alcohol-Associated Liver Disease of Infectious and Non-Infectious Origin.非实质肝细胞在感染性和非感染性酒精性肝病中的致病作用
Biology (Basel). 2023 Feb 6;12(2):255. doi: 10.3390/biology12020255.
10
Male-Specific Activation of Lysine Demethylases 5B and 5C Mediates Alcohol-Induced Liver Injury and Hepatocyte Dedifferentiation.赖氨酸去甲基酶 5B 和 5C 的雄性特异性激活介导酒精性肝损伤和肝实质细胞去分化。
Hepatol Commun. 2022 Jun;6(6):1373-1391. doi: 10.1002/hep4.1895. Epub 2022 Jan 27.

本文引用的文献

1
Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease.瞬时弹性成像技术检测肝脏硬度可预测慢性肝病患者的肝脏相关并发症和死亡率。
PLoS One. 2014 Apr 22;9(4):e95776. doi: 10.1371/journal.pone.0095776. eCollection 2014.
2
The feasibility and reliability of transient elastography using Fibroscan®: a practice audit of 2335 examinations.利用 Fibroscan®进行瞬时弹性成像的可行性和可靠性:2335 次检查的实践审核。
Can J Gastroenterol Hepatol. 2014 Mar;28(3):143-9. doi: 10.1155/2014/952684.
3
A histologic scoring system for prognosis of patients with alcoholic hepatitis.酒精性肝炎患者预后的组织学评分系统。
Gastroenterology. 2014 May;146(5):1231-9.e1-6. doi: 10.1053/j.gastro.2014.01.018. Epub 2014 Jan 15.
4
Hospital performance reports based on severity adjusted mortality rates in patients with cirrhosis depend on the method of risk adjustment .基于肝硬化患者校正死亡率的医院绩效报告取决于风险调整方法。
Ann Hepatol. 2012 Jul-Aug;11(4):526-35.
5
Comparison of Maddrey Discriminant Function, Child-Pugh Score and Glasgow Alcoholic Hepatitis Score in predicting 28-day mortality on admission in patients with acute hepatitis.比较 Maddrey 判别函数、Child-Pugh 评分和 Glasgow 酒精性肝炎评分在预测急性肝炎患者入院 28 天死亡率中的作用。
Ir J Med Sci. 2013 Mar;182(1):63-8. doi: 10.1007/s11845-012-0827-4. Epub 2012 Apr 28.
6
Validation of prognostic scores for clinical use in patients with alcoholic hepatitis.酒精性肝炎患者临床应用预后评分的验证
Scand J Gastroenterol. 2011 Sep;46(9):1127-32. doi: 10.3109/00365521.2011.587200. Epub 2011 May 18.
7
Alcoholic liver disease.酒精性肝病
Hepatology. 2010 Jan;51(1):307-28. doi: 10.1002/hep.23258.
8
Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study.加拿大某健康地区原发性胆汁性肝硬化的流行病学及自然史:一项基于人群的研究。
Hepatology. 2009 Dec;50(6):1884-92. doi: 10.1002/hep.23210.
9
Alcoholic hepatitis.酒精性肝炎
N Engl J Med. 2009 Jun 25;360(26):2758-69. doi: 10.1056/NEJMra0805786.
10
Predicting in-hospital mortality in patients with cirrhosis: results differ across risk adjustment methods.预测肝硬化患者的院内死亡率:不同风险调整方法的结果存在差异。
Hepatology. 2009 Feb;49(2):568-77. doi: 10.1002/hep.22676.

酒精性肝炎患者死亡的危险因素及预后模型评估:一项基于人群的研究。

Risk factors for mortality in patients with alcoholic hepatitis and assessment of prognostic models: A population-based study.

出版信息

Can J Gastroenterol Hepatol. 2015 Apr;29(3):131-8. doi: 10.1155/2015/814827.

DOI:10.1155/2015/814827
PMID:25855876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4399372/
Abstract

BACKGROUND

Severe alcoholic hepatitis (AH) is associated with a substantial risk for short-term mortality.

OBJECTIVES

To identify prognostic factors and validate well-known prognostic models in a Canadian population of patients hospitalized for AH.

METHODS

In the present retrospective study, patients hospitalized for AH in Calgary, Alberta, between January 2008 and August 2012 were included. Stepwise logistic regression models identified independent risk factors for 90-day mortality, and the discrimination of prognostic models (Model for End-stage Liver Disease [MELD] and Maddrey discriminant function [DF]) were examined using areas under the ROC curves.

RESULTS

A total of 122 patients with AH were hospitalized during the study period; the median age was 49 years (interquartile range [IQR] 42 to 55 years) and 60% were men. Median MELD score and Maddrey DF on admission were 21 (IQR 18 to 24) and 45 (IQR 26 to 62), respectively. Seventy-three percent of patients received corticosteroids and⁄or pentoxifylline, and the 90-day mortality was 17%. Independent predictors of mortality included older age, female sex, international normalized ratio, MELD score and Maddrey DF (all P<0.05). For discrimination of 90-day mortality, the areas under the ROC curves of the prognostic models (MELD 0.64; Maddrey DF 0.68) were similar (P>0.05). At optimal cut-offs of ≥22 for MELD score and ≥37 for Maddrey DF, both models excluded death with high certainty (negative predictive values 90% and 96%, respectively).

CONCLUSIONS

In patients hospitalized for AH, well-known prognostic models can be used to predict 90-day mortality, particularly to identify patients with a low risk for death.

摘要

背景

严重酒精性肝炎(AH)与短期死亡率有很大的关系。

目的

在加拿大 AH 住院患者人群中确定预后因素并验证已知的预后模型。

方法

在这项回顾性研究中,纳入了 2008 年 1 月至 2012 年 8 月在阿尔伯塔省卡尔加里住院的 AH 患者。逐步逻辑回归模型确定了 90 天死亡率的独立危险因素,并通过 ROC 曲线下面积来检验预后模型(终末期肝病模型 [MELD]和 Maddrey 判别函数 [DF])的区分能力。

结果

研究期间共有 122 例 AH 患者住院,中位年龄为 49 岁(四分位间距 [IQR] 42-55 岁),60%为男性。入院时中位 MELD 评分和 Maddrey DF 分别为 21(IQR 18-24)和 45(IQR 26-62)。73%的患者接受了皮质激素和/或己酮可可碱治疗,90 天死亡率为 17%。死亡率的独立预测因素包括年龄较大、女性、国际标准化比值、MELD 评分和 Maddrey DF(均 P<0.05)。对于 90 天死亡率的判别,预后模型的 ROC 曲线下面积(MELD 为 0.64;Maddrey DF 为 0.68)相似(P>0.05)。在 MELD 评分≥22 和 Maddrey DF≥37 的最佳截断值下,两种模型都可以高度确定排除死亡(阴性预测值分别为 90%和 96%)。

结论

在 AH 住院患者中,可使用已知的预后模型预测 90 天死亡率,尤其是可以识别低死亡风险的患者。